查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433435

全球外骨骼市场 2023-2030

Global Exoskeleton Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 210 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2024-2031年），全球外骨骼市场将以 12.4% 的CAGR成长。推动外骨骼市场的重要因素包括脊髓损伤发生率的上升、外骨骼研发投资的增加以及政府政策的凝聚力。根据国家脊髓损伤统计中心 (NSCISC) 2023 年的数据，美国创伤性脊髓损伤 (tSCI) 的年发病率最新估计约为每百万人 54 例，相当于每年约新增 18,000 例 tSCI 病例年。此外，私营和公共部门对外骨骼技术开发的投资不断增加，进一步促进了市场成长。 2023 年 12 月，剑桥外骨骼开发商 Verve Motion 筹集了 2000 万美元的 B 轮资金，以扩大其 SafeLift 软外骨骼的规模。 SafeLift 像背包一样穿着，利用即时运动感应和机器人辅助，可减轻典型工作日工人背部 40% 的压力。

细分市场前景

全球外骨骼市场按类型、移动性和最终用户进行细分。根据类型，市场分为动力外骨骼和被动外骨骼。根据移动性，市场分为移动和固定/固定。此外，根据最终用户，市场分为医疗、工业和军事。在这些类型中，动力外骨骼细分市场预计将占据很大的市场份额，这主要归因于减少工业中的身体压力、提高生产力和復健支持。

预计行动细分市场将在全球外骨骼市场中占据相当大的份额

在行动领域中，行动细分市场预计将在全球外骨骼市场中占据相当大的份额。此细分市场的成长归因于为行动不便的个人提供站立能力、促进独立性和提高生活质量，以及移动外骨骼技术的不断进步和监管部门的批准。此外，主要参与者也在不同地区拓展业务，以满足移动外骨骼的需求。例如，2023 年 10 月，Wandercraft 与凯斯勒基金会合作，在美国推出了 Atalante X 移动外骨骼的商业运作。这款免持设备经 FDA 批准用于中风康復，利用自平衡技术和游戏化功能进行物理治疗。在 2022 年 12 月获得 FDA 批准 Atalante 用于中风復原后，Wandercraft 策略性地扩大了在美国的足迹。该公司在纽约建立了新的营运基地，以增强其市场影响力并支援 Atalante 在该地区的部署。该设备于 2019 年获准在欧盟使用，此后已用于治疗 650 多名患者，进行了 5,000 多次治疗。

区域展望

全球外骨骼市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国、亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于外骨骼在军事和国防应用中的使用越来越多，包括士兵增强和负重辅助，预计欧洲将在全球市场中占据显着份额，这有助于欧洲市场的扩张。

北美地区预计全球外骨骼市场复合CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域市场的成长归因于医疗保健中越来越多地采用外骨骼进行復健和政府的支持性倡议，以及工业环境中越来越多地采用外骨骼以提高工人的安全和生产力。根据美国劳工统计局的数据，2022年美国有5,486起致命工伤，比2021年的5,190起增加了5.7%。致命工伤率为每10万名全职当量工人中有3.7人死亡，到2021 年，每10 万名全职员工中的3.6 人将增加。此外，外骨骼製造商、技术公司和研究机构之间不断加强的合作也促进了该地区的创新和市场成长。 2024 年 1 月，理查德和洛恩希尔生物医学工程系的 Ming Wu 教授获得了伊利诺伊大学芝加哥分校和 OSF Healthcare 的合作资助，用于创建用于护理的外骨骼。该计画旨在为护理人员製造外骨骼，以避免与重复性任务和长时间轮班相关的腰痛和受伤风险。

市场参与者展望

服务外骨骼市场的主要公司包括 Bionik Laboratories、Bioness Inc.、Cyber​​dyne Inc.、Ekso Bionics Holdings, Inc.、ReWalk Robotics Ltd. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 6 月，Ekso Bionics 为其专为多发性硬化症 (MS) 患者设计的 EksoNR 机器人外骨骼获得了 FDA 510(k) 许可。这标誌着 FDA 首次批准外骨骼復健用于多发性硬化症患者，从而扩大了该设备的应用范围。

报告涵盖：

  • 2023年市场价值资料分析及2031年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球外骨骼市场中营运的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Bionik Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Bioness Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Cyberdyne Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Ekso Bionics Holdings, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • ReWalk Robotics Ltd.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球外骨骼市场
    • 动力外骨骼
    • 被动外骨骼
  • 按移动性分類的全球外骨骼市场
    • 移动的
    • 固定/固定
  • 按最终用户分類的全球外骨骼市场
    • 医疗的
    • 工业的
    • 军队

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 3DR, Inc.
  • American Honda Motor Co., Inc.
  • ATOUN Inc.
  • B-Temia Inc.
  • Hocoma AG
  • Lockheed Martin Corp.
  • Myomo Inc.
  • noonee germany GmbH
  • Parker Hannifin Corp.
  • Rex Bionics Ltd
  • Roam Robotics
  • Sarcos Technology and Robotics Corp.
  • SuitX
  • US Bionics, Inc.
Product Code: OMR2028086

Global Exoskeleton Market Size, Share & Trends Analysis Report by Type (Powered Exoskeletons and Passive Exoskeletons), by Mobility (Mobile and Fixed/Stationary), and by End-User (Medical, Industrial, and Military), Forecast Period (2024-2031)

The global exoskeleton market is anticipated to grow at a CAGR of 12.4% during the forecast period (2024-2031). Significant factors contributing to the exoskeleton market include the growing incidence rate of spinal cord injuries, increasing investment in R&D of the exoskeleton, and cohesive government policies. As per the National Spinal Cord Injury Statistical Center (NSCISC) 2023, the most recent estimate of the annual incidence of traumatic spinal cord injury (tSCI) is approximately 54 cases per one million people in the US, which equals about 18,000 new tSCI cases each year. Additionally, growing investments from private and public sectors in the development of exoskeleton technologies further contribute to market growth. In December 2023, Verve Motion, a Cambridge-based exoskeleton developer, raised $20 million in Series B funding to scale its SafeLift soft exoskeleton. SafeLift, worn like a backpack, utilizes real-time motion sensing and robotic assistance to alleviate 40% of the strain on a worker's back during a typical workday.

Segmental Outlook

The global exoskeleton market is segmented by type, mobility, and end-user. Based on the type, the market is sub-segmented into powered exoskeletons and passive exoskeletons. Based on mobility, the market is sub-segmented into mobile and fixed/stationary. Further, based on the end-user, the market is sub-segmented into medical, industrial, and military. Among the types, the powered exoskeletons sub-segment is projected to hold a significant share of the market, primarily attributed to reducing physical strain in industries, improving productivity, and rehabilitation support.

The Mobile Sub-Segment is Anticipated to Hold a Considerable Share of the Global Exoskeleton Market

Among the mobility, the mobile sub-segment is expected to hold a considerable share of the global exoskeleton market. The segmental growth is attributed to providing individuals with mobility impairments the ability to stand, promoting independence and improved quality of life, and continuous advancements in mobile exoskeleton technology, and regulatory approvals. In addition, the key players are also expanding their business in different regions to cater to the demand for mobile exoskeletons. For instance, in October 2023, Wandercraft launched commercial operations in the US for its Atalante X mobility exoskeleton, partnering with the Kessler Foundation. FDA-approved for stroke rehabilitation, the hands-free device utilizes self-balancing technology and gamified features for engaging in physiotherapy. After securing FDA approval in December 2022 for Atalante's utilization in stroke rehabilitation, Wandercraft strategically expanded its footprint in the US. The company established a new operational base in New York to enhance its market presence and support the deployment of Atalante in the region. The device was approved for use in the EU in 2019 and has since been used to treat over 650 patients across over 5,000 sessions.

Regional Outlook

The global exoskeleton market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the growing use of exoskeletons in military and defense applications, including soldier augmentation and load-bearing assistance, which contributes to market expansion in Europe.

The North America Region is Expected to Grow at a Significant CAGR in the Global Exoskeleton Market

Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. The regional market growth is attributed to the growing adoption of exoskeletons in healthcare for rehabilitation and supportive government initiatives and the increasing adoption of exoskeletons in industrial settings to enhance worker safety and productivity. According to the US Bureau of Labor Statistics, there were 5,486 fatal work injuries recorded in the US in 2022, marking a 5.7% increase from the 5,190 recorded in 2021. The fatal work injury rate was 3.7 fatalities per 100,000 full-time equivalent workers, up from 3.6 per 100,000 full-time equivalents in 2021. In addition, increasing collaborations between exoskeleton manufacturers, technology firms, and research institutions bolster innovation and market growth in the region. In January 2024, Prof. Ming Wu at the Richard and Loan Hill Department of Biomedical Engineering received a collaborative grant from the University of Illinois Chicago and OSF Healthcare to create an exoskeleton for nursing. The project aimed to create an exoskeleton for nursing staff to avoid lower back pain and injury risks associated with repetitive tasks and long shifts.

Market Players Outlook

The major companies serving the exoskeleton market include Bionik Laboratories, Bioness Inc., Cyberdyne Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2022, Ekso Bionics received FDA 510(k) clearance for its EksoNR robotic exoskeleton designed for Multiple Sclerosis (MS) patients. This marked the first FDA clearance for exoskeleton rehabilitation use in MS patients, broadening the device's application.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global exoskeleton market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Bionik Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bioness Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Cyberdyne Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Ekso Bionics Holdings, Inc.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. ReWalk Robotics Ltd.
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Exoskeleton Market by Type
    • 4.1.1. Powered Exoskeletons
    • 4.1.2. Passive Exoskeletons
  • 4.2. Global Exoskeleton Market by Mobility
    • 4.2.1. Mobile
    • 4.2.2. Fixed/Stationary
  • 4.3. Global Exoskeleton Market by End-User
    • 4.3.1. Medical
    • 4.3.2. Industrial
    • 4.3.3. Military

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3DR, Inc.
  • 6.2. American Honda Motor Co., Inc.
  • 6.3. ATOUN Inc.
  • 6.4. B-Temia Inc.
  • 6.5. Hocoma AG
  • 6.6. Lockheed Martin Corp.
  • 6.7. Myomo Inc.
  • 6.8. noonee germany GmbH
  • 6.9. Parker Hannifin Corp.
  • 6.10. Rex Bionics Ltd
  • 6.11. Roam Robotics
  • 6.12. Sarcos Technology and Robotics Corp.
  • 6.13. SuitX
  • 6.14. US Bionics, Inc.

LIST OF TABLES

  • 1. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 2. GLOBAL POWERED EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3. GLOBAL PASSIVE EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 5. GLOBAL MOBILE EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 6. GLOBAL FIXED/STATIONARY EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 7. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 8. GLOBAL EXOSKELETON FOR MEDICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9. GLOBAL EXOSKELETON FOR INDUSTRIAL MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 10. GLOBAL EXOSKELETON FOR MILITARY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 11. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 12. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 13. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 14. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 15. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 16. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 17. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 18. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 19. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 20. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 21. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 22. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 23. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 24. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 25. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 26. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 27. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL EXOSKELETON MARKET SHARE BY TYPE, 2023 VS 2031 (%)
  • 2. GLOBAL POWERED EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 3. GLOBAL PASSIVE EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 4. GLOBAL EXOSKELETON MARKET SHARE BY MOBILITY, 2023 VS 2031 (%)
  • 5. GLOBAL MOBILE EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 6. GLOBAL FIXED/STATIONARY EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 7. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023 VS 2031 (%)
  • 8. GLOBAL EXOSKELETON FOR MEDICAL MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 9. GLOBAL EXOSKELETON FOR INDUSTRIAL MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 10. GLOBAL EXOSKELETON FOR MILITARY MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 11. GLOBAL EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 12. US EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 13. CANADA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 14. UK EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 15. FRANCE EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 16. GERMANY EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 17. ITALY EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 18. SPAIN EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 19. REST OF EUROPE EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 20. INDIA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 21. CHINA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 22. JAPAN EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 23. SOUTH KOREA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 25. REST OF THE WORLD EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)